RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

Golan, Talia, Khvalevsky, Elina Zorde, Hubert, Ayala, Gabai, Rachel Malka, Hen, Naama, Segal, Amiel, Domb, Abraham, Harari, Gil +10 more·2015·Oncotarget
DOI 10.18632/oncotarget.4183

Cited by (336)

Items 201–300 of 336

  1. Advancing cancer treatment: in vivo delivery of therapeutic small noncoding RNAs
    Xiaoyue Yang, Ying Liang, Sheng Tong · 2024 · Frontiers in Molecular Biosciences
  2. Genetic Signature of Human Pancreatic Cancer and Personalized Targeting
    Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai · 2024 · Cells
  3. Assembling the RNA therapeutics toolbox
    Mona Teng, Ziting Judy Xia, Nicholas Lo, Kashif Daud, Housheng Hansen He · 2024 · Medical Review
  4. Impact of drug dispersion on tumor-effector dynamics during combined chemo-immunotherapy with sensitivity analysis
    Lazaro Revocatus Mashiku, J. P. Ndenda, Reuben S. Maghembe, Sachin Shaw · 2024 · Applied Mathematical Modelling
  5. Breakthroughs in nanoparticle-based strategies for pancreatic cancer therapy
    Sara Escalera-Anzola, Maria Rosado, Yuchen Yang, Daniel Parra Sánchez, Carolina San Pedro-Liberal, Pilar Acedo · 2024 · Biochemical Pharmacology
  6. Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
    Tuan Anh Hoang, Erica S. Tsang · 2025 · Journal of Gastrointestinal Cancer
  7. Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL)
    Mahsa Mir Mohseni, Cezary Kucharski, Remant Bahadur K.C., Mohammad Nasrullah, Xiaoyan Jiang, Hasan Uludağ, Joseph M. Brandwein · 2021 · PLoS ONE
  8. Muscle Regeneration and RNA: New Perspectives for Ancient Molecules
    Giulia Buonaiuto, Fabio Desideri, Valeria Taliani, Monica Ballarino · 2021 · Cells
  9. Broadening the Horizons of RNA Delivery Strategies in Cancer Therapy
    Shuaiying Wu, Chao Liu, Shuang Bai, Zhixiang Lu, Gang Liu · 2022 · Bioengineering
  10. MicroRNA‐Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer
    Sriganesh B. Sharma, John Michael Ruppert · 2015 · Drug Development Research
  11. Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality
    Timothy R. Donahue, David W. Dawson · 2016 · Trends in Endocrinology and Metabolism
  12. Targeting siRNAs in cancer drug delivery
    Mohammad A. Obeid, Alaa A. A. Aljabali, Walhan Alshaer, Nitin B. Charbe, Dinesh Kumar Chellappan, Kamal Dua, Saurabh Satija, Murtaza M. Tambuwala · 2021 · Elsevier eBooks
  13. Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy
    Michail Galanopoulos, Aris Doukatas, Filippos Gkeros, Nikos Viazis, Christos N. Liatsos · 2021 · World Journal of Gastroenterology
  14. Nucleic Acid-Based Approaches to Tackle KRAS Mutant Cancers
    Jimi Kim · 2023 · International Journal of Molecular Sciences
  15. Gene regulations and delivery vectors for treatment of cancer
    Ming Chen, Yuxin Ren, Ying Xie, Wan-Liang Lü · 2020 · Journal of Pharmaceutical Investigation
  16. Safety and effectiveness of interference RNA (RNAi) based therapeutics in cardiac failure: A systematic review
    Muhammad Nabeel Saddique, Maria Qadri, Noor ul Ain, Eesha Farhan, Fatima Shahid, Javeria Benyamin, Muhammad Atif Bashir, Hritvik Jain, Javed Iqbal · 2024 · Heart & Lung
  17. Gene expression silencing therapy in tumors, focus on gastrointestinal and genitourinary tumors
    Nathan El-Ghazzi, Antoîne Italiano, Eurydice Angeli · 2025 · Frontiers in Immunology
  18. KRAS-targeted therapies in cancer: novel approaches and overcoming resistance
    Daolin Tang, Guido Kroemer, Rui Kang · 2025 · BMJ Oncology
  19. KRAS Inhibition in Pancreatic Ductal Adenocarcinoma
    Roshini Pradeep, Nooredeen Jamal Isbeih, Freya F. Abraham, Ehsan Noori, Zachary Phillip Yeung, Madappa N. Kundranda · 2026 · Journal of Clinical Medicine
  20. Discovery platforms for RNA therapeutics
    Giulio Ciucci, Luca Braga, Serena Zacchigna · 2024 · British Journal of Pharmacology
  21. Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging
    Yoghalakshmi Nagarajan, Natarajan Chandrasekaran, Venkatachalam Deepa Parvathi · 2024 · ChemistryOpen
  22. Are Probiotics Beneficial or Harmful for Pancreatic Cancer Outcomes?
    Tae Seung Lee · 2024 · Probiotics and Antimicrobial Proteins
  23. siRNA Design and GalNAc-Empowered Hepatic Targeted Delivery
    Mei Lu, Mengjie Zhang, Bo Hu, Yuanyu Huang · 2021 · Methods in molecular biology
  24. Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance
    Apostolis Papaefthymiou, Aris Doukatas, Michail Galanopoulos · 2022 · Clinics and Research in Hepatology and Gastroenterology
  25. Innovative nonviral vectors for small-interfering RNA delivery and therapy
    Danielle Campiol Arruda, Céline Hoffmann, Christine Charrueau, Pascal Bigey, Virginie Escriou · 2017 · Elsevier eBooks
  26. Epigenetic Modulation and Bone Metastasis: Evolving Therapeutic Strategies
    Mahmoud Zhra, Jasmine Holail, Khalid Said Mohammad · 2025 · Pharmaceuticals
  27. Micelleplex nucleic acid delivery systems: Overcoming barriers for treatment of advanced solid tumors
    Abolfazl Doustmihan, Morteza Akbari, Mehdi Jaymand, Guodong Liu, Rana Jahanban‐Esfahlan · 2025 · Materials & Design
  28. The role of ncRNA in the co-regulation of autophagy and exosome pathways during cancer progression
    Naveen Soni, Gargi Nandi, Megha Chaudhary, Bhawana Bissa · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  29. Advances in RNA therapeutics for modulation of ‘undruggable’ targets
    Emily Martinsen, Tasmia Jinnurine, Saranya Subramani, Marie Rogne · 2024 · Progress in molecular biology and translational science
  30. Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutations
    Swati Dudhal, Lylia Mekzine, Bernard Prudhon, Karishma Soocheta, Bruno Cadot, Kamel Mamchaoui, Delphine Trochet, Marc Bitoun · 2022 · Molecular Therapy — Nucleic Acids
  31. YB-1 activating cascades as potential targets in KRAS-mutated tumors
    Shayan Khozooei, Soundaram Veerappan, Mahmoud Toulany · 2023 · Strahlentherapie und Onkologie
  32. Ubiquitin‐independent, Proteasome‐mediated targeted degradation of KRAS in pancreatic adenocarcinoma cells using an engineered ornithine decarboxylase/antizyme system
    Yihui Ma, Jingjing Xu, Pei Huang, Xue Bai, Gao Hanqing · 2018 · IUBMB Life
  33. Global and Chinese trends in oligonucleotide drug clinical development: A comparative analysis
    Xiaofei Wu, Shupeng Liu, Dan Liu, Xiuqi Li, Hongyun Wang, Xiaohong Han · 2024 · Pharmacological Research
  34. Advances in neoadjuvant therapy for pancreatic cancer: Current trends and future directions
    Shang‐Gin Wu, Li Zhu, Feng Xiao-ling, Yang Li, Guowei Chen, Yan Jiang, Ting-Fang Huang, Haoyu Wang, Fang Li · 2025 · World Journal of Clinical Oncology
  35. Therapeutic Oligonucleotides Against Cancer: Recent Approaches and New Perspectives
    Giovanni Palomino-Vizcaíno, Luis Marat Álvarez-Salas · 2019 · Elsevier eBooks
  36. Intelligent drug delivery systems
    Sepehr Talebian, Javad Foroughi · 2020 · Elsevier eBooks
  37. Cancer biology functional genomics: From small RNAs to big dreams
    Soumya Sundara Rajan, Katelyn R. Ludwig, Katherine L. Hall, Tamara L. Jones, Natasha J. Caplen · 2020 · Molecular Carcinogenesis
  38. Anticancer effect of locally applicable aptamer‐conjugated gemcitabine‐loaded atelocollagen patch in pancreatic cancer patient–derived xenograft models
    Seung Soo Hong, Se‐Na Lee, Sung Hwan Lee, Seonhowa Kim, 김도영, Hanseul Park, Jongook Lee, Jung Hwan Lee, Chang Moo Kang · 2022 · Cancer Science
  39. Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors
    Pasquale Losurdo, Nicolò de Manzini, Silvia Palmisano, Mario Grassi, Salvatore Parisi, Flavio Rizzolio, Domenico Tierno, Alice Biasin, Chiara Grassi, Nhung Hai Truong et al. · 2022 · Pharmaceuticals
  40. Nanocarriers as drug delivery system for chemotherapeutic agents: from inception to clinical implementation
    Talha Zubair, Sheikh Arefin Rashid, Nishat Laila Bristy, Somnath Banik, Shanjida Sultana, Tanjum Jahan Mojumder, Rafsana Binte Ashraf, Abdullah‐Al Masum · 2025 · Drug Development and Industrial Pharmacy
  41. RNA-based drugs: current, imminent and possible therapeutic applications
    Sebastiano Alfio Torrisi, Federica Geraci, Lidia Diolosà, Angelina De Luca, Luca Falzone, Filippo Drago, Massimo Libra, Gian Marco Leggio · 2025 · Pharmacology & Therapeutics
  42. Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy
    Barbara Geerinckx, Laure-Anne Marie Nicole Teuwen, Tiffany Foo, Timon Vandamme, Annabel Smith, Marc Peeters, Timothy Jay Price · 2023 · Expert Review of Anticancer Therapy
  43. Targeting pediatric solid tumors in the new era of RNA therapeutics
    Parunya Chaiyawat, Surasak Sangkhathat, Wararat Chiangjong, Patompon Wongtrakoongate, Suradej Hongeng, Dumnoensun Pruksakorn, Somchai Chutipongtanate · 2024 · Critical Reviews in Oncology/Hematology
  44. Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment
    Hamed Tabasi, Samaneh Mollazadeh, Elham Fazeli, Khalil Abnus, Seyed Mohammad Taghdisi, Mohammad Ramezani, Mona Alibolandi · 2023 · Applied Biochemistry and Biotechnology
  45. Endoscopic Ultrasound-Guided Locoregional Treatments for Solid Pancreatic Neoplasms
    Luca Di Gialleonardo, Giulia Tripodi, Gianenrico Rizzatti, Maria Elena Ainora, Cristiano Spada, Alberto Larghi, Antonio Gasbarrini, Maria Assunta Zocco · 2023 · Cancers
  46. Anti-tumour drugs of marine origin currently at various stages of clinical trials (review)
    Е. А. Бочарова, Н. И. Копытина, Е. Е. Slynko · 2021 · Regulatory Mechanisms in Biosystems
  47. βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells
    Simon Brayford, Alastair M. P. Duly, Wee Siang Teo, Tanya M. Dwarte, Estrella Gonzales‐Aloy, Zerong Ma, Laura E. McVeigh, Timothy W. Failes, Greg M. Arndt, Joshua A. McCarroll et al. · 2022 · Cancer Medicine
  48. RAS: Circuitry and therapeutic targeting
    Gagandeep Singh, Neelam Thakur, Umesh Kumar · 2022 · Cellular Signalling
  49. Breaking the Fourth Wall: Modulating Quaternary Associations for Protein Regulation and Drug Discovery
    Marcus J. C. Long, Dziyana Hnedzko, Bo Kyoung Kim, Yimon Aye · 2018 · ChemBioChem
  50. Therapeutic siRNA: Mechanisms, challenges, strategies, and clinical translation
    Qiping Jiang, Junjun Fu, Yacong An, Yuqin Liu · 2026 · Chinese Medical Journal
  51. Small non-coding RNAs as therapeutic targets with delivery strategies in cancer treatment and their clinical applications
    Sema Mısır, Alaa A. A. Aljabali, Serap Özer Yaman, Nina Petrović, Mohammad A. Obeid · 2025 · International Journal of Pharmaceutics
  52. Delivery of siRNAs Against Selective Ion Channels and Transporter Genes Using Hyaluronic Acid-coupled Carbonate Apatite Nanoparticles Synergistically Inhibits Growth and Survival of Breast Cancer Cells
    Mohammad Borhan Uddin, Mark M. Banaszak Holl, Ezharul Hoque Chowdhury · 2024 · International Journal of Nanomedicine
  53. Potential therapies for non-coding RNAs in breast cancer
    Ruonan Li, Yuxin Ji, Ruyin Ye, Guohui Tang, Wenrui Wang, Changjie Chen, Qingling Yang · 2024 · Frontiers in Oncology
  54. Lipid nanoparticle-based delivery of small interfering RNAs: New possibilities in the treatment of diverse diseases
    Anis Askarizadeh, Fatemeh Vahdat‐Lasemi, Sercan Karav, Prashant Kesharwani, Amirhossein Sahebkar · 2024 · European Polymer Journal
  55. Targeted RNA Degradation via LipoSM-RiboTAC Nanoparticles: A Versatile Platform for Cancer Therapy
    Zi-Jun Jiao, Chunli Song, Xinrui Sha, Ying Chen, Yun Xing, Fuqing Yang, Rui Ying Wang, Yuxin Ye, Zhihong Liu, Zi‐You Tian et al. · 2025 · Journal of the American Chemical Society
  56. Frontiers in glioblastoma therapy: Novel therapeutics, molecular pathways, and future clinical perspectives
    Sandeep Pandey, Akanksha Dwivedi, Ranjana Singh, Nimra Habib, Dharmendra Kashyap, Vaishali Saini, Arjit Singh, Ankit Sharma, Hem Chandra Jha · 2025 · Human Gene
  57. The Potential of Noncoding RNAs-siRNAs in Cancer Research and Therapy: Challenges and Solutions
    Himanshu, Mudasir Bashir, Moien Rasheed Lone, Mohsin Maqbool · 2026 · Experientia supplementum
  58. Systematic and precise interventions for KRAS-mutant cancers
    JingHui Liang, JunXi Wu, Yuan Zhang, Hongyu Wang, YiYang Zheng, Qing He · 2026 · Experimental Hematology and Oncology
  59. Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm
    Cody R. Eslinger, Mohamad Bassam Sonbol, Ben George, Hani Babiker, Mitesh J. Borad, Tanios Bekaii‐Saab · 2026 · Drug Design Development and Therapy
  60. Next-generation long-acting injectables: Technological innovations and patient-centric design in complex drug delivery systems
    Naitik Jain, Abhijeet P. Pandey, Srinivas Mutalik · 2026 · Journal of Drug Delivery Science and Technology
  61. Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives
    María Carretero-Fernández, Lucía Ruiz-Durán, Pinar Uysal Onganer, Neil Daniel, Eugenia Ch. Yiannakopoulou, Burçak Otlu, Francisco José García‐Verdejo, José A López-López, Francisco G. Ortega, Marco Bonilla et al. · 2026 · Biomedicine & Pharmacotherapy
  62. Nanomaterial-Mediated Nucleic Acid Delivery for Pancreatic Cancer Therapeutics
    Urmica Nandy, Abul Kalam Azad Mandal, Pranav Tiwari · 2025 · ACS Applied Bio Materials
  63. Perspective Chapter: RNA Therapeutics for Cancers
    Michiko Kurikawa, Marimu Sakumoto, Akihide Yoshimi · 2022 · IntechOpen eBooks
  64. Targeting siRNA nanoparticles with ApoB peptide: Formulation, biodistribution, and bioactivity in pancreatic tumor-bearing mice
    Majd Agbaria, Doaa Jbara-Agbaria, Gershon Golomb · 2025 · Journal of Drug Delivery Science and Technology
  65. RNAi technique, how far is it from pediatrics?
    Getu Zhaori · 2017 · Pediatric Investigation
  66. Delivery of nucleic acids to ex vivo porcine airways using electrospray
    Peter Riddell, Jennifer L. Gilbert, Emer L. Molloy, S Finnegan, Jim John Egan, Shirley O’Dea · 2018 · Experimental Lung Research
  67. Implantable and long-lasting drug delivery systems for cancer treatment
    Catarina Pacheco, Ana Baião, Flávia Sousa, Bruno Filipe Carmelino Cardoso Sarmento · 2021 · Elsevier eBooks
  68. Advancements in siRNA delivery using nanotechnology for reproductive tract cancers: From targeting to enhancing treatment efficacy
    Krishna Kant Jangde, Dinesh Kumar Mishra · 2024 · Journal of Reproductive Healthcare and Medicine
  69. Driving Precision Medicine in Pancreatic Cancer With Molecular Genetics
    Maria Farooq, Michael Jon Pishvaian · 2025 · Seminars in Radiation Oncology
  70. Shifting tides from non-targeted chemotherapy to targeted therapies and small RNA-based bio drugs: A changing paradigm in cancer therapy
    Mridul Gautam, Chethana D. Kumar, Pournami Ramachandran, Aviral Kumar, Indresh K Gopalsamy, Guruprasadh Swaminathan, Marco Cordani, Lekha Dinesh Kumar · 2025 · European Journal of Pharmacology
  71. Targeting KRAS for cancer therapy
    Jianlong Jia, Ruonan Liu, Tonia A. Adamide, Isis E. Fernandez, Georgios T. Stathopoulos · 2026 · British Journal of Pharmacology
  72. Progress in siRNA nucleic acid therapeutics and challenges in their application to cancer treatment
    Kumiko Ui‐Tei · 2026 · Japanese Journal of Clinical Oncology
  73. Endoscopic innovations in diagnosis and management of pancreatic cancer: a narrative review and future directions
    Prateek Suresh Harne, Vaishali Harne, Curtis Jackson Wray, Nirav C Thosani · 2024 · Therapeutic Advances in Gastroenterology
  74. Could Drug Delivery Systems Be Enhancers for Therapy against KRAS-driven Cancers?
    Ramil Khusnutdinov · 2024 · Reviews and Advances in Chemistry
  75. Cut and Paste for Cancer Treatment: A DNA Nanodevice that Cuts Out an RNA Marker Sequence to Activate a Therapeutic Function
    Tatiana A. Molden, Caitlyn T. Niccum, Dmitry M. Kolpashchikov · 2020 · Angewandte Chemie
  76. Advances on nucleic acid delivery with nonviral vectors
    R.M. Lopes, Nuno André Fonseca, Ana Filipa Cruz, Ana C. Gregório, Ângela Valério-Fernandes, Vera Moura, Sérgio Simões, João Nuno Moreira · 2016 · Elsevier eBooks
  77. Uncoupling the Oncogenic Engine
    Axel Schambach, Juliane Wilhelmine Schott, Michael Alexander Morgan · 2017 · Cancer Research
  78. Precision Medicine Based on Next-Generation Sequencing and Master Controllers
    Katerina Dukleska, Charles J. Yeo, Michael Jon Pishvaian, Jonathan Robert Brody · 2018 · Springer eBooks
  79. Targeted delivery systems for treatment of pancreatic cancer
    Melek Karaca, Yıldız Özsoy · 2019 · Elsevier eBooks
  80. Equipment and Accessories for Therapeutic Endoscopic Ultrasound
    Mihai Rimbaș, Alberto Larghi · 2020 · Springer eBooks
  81. Emerging agents for metastatic pancreatic cancer: spotlight on early phase clinical trials
    Byung Woog Kang, Ian Chau · 2021 · Expert Opinion on Investigational Drugs
  82. Oncogenic RAS Networks Suppression: Reversibly Ionic Oligonucleotide‐Based Nanoparticles Caged microRNA‐143 Inhibit KRAS‐Mutated Colon Cancer Growth in Tumor‐Bearing Mice
    Noriko Miyamoto, Riku Kawasaki, Mina Sakuragi, Keita Yamana, Hinata Isozaki, Shogo Kawamura, Isamu Akiba, Yukio Kitade · 2022 · Advanced Therapeutics
  83. Targeted Therapies for Pancreatic Cancer
    Michael S. Lee, Shubham Pant · 2023 · Springer eBooks
  84. Endoscopic ultrasound role in pancreatic adenocarcinoma treatment: A review focusing on technical success, safety and efficacy
    Wisam Sbeit, Bertrand Napoléon, Tawfik Khoury · 2022 · World Journal of Gastroenterology
  85. siRNA-coupled nanoparticles for improved therapeutic targeting of pancreatic cancer
    Sebastian Lange, Dieter Saur, Roland Rad · 2016 · Gut
  86. Targeting KRAS mutation in gastrointestinal cancers
    Fuat Bicer, Mehmet Akce, Gary Anthony Piazza, Jeremy B. Foote, Bassel F. El‐Rayes · 2023 · F1000Research
  87. Comprehensive analysis of KRAS aberrations in pan-cancer, with a focus on prognostic and therapeutic implications
    Jaeyun Jung, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Jeeyun Lee, Sang Yun Ha, Soomin Ahn et al. · 2025 · Therapeutic Advances in Medical Oncology
  88. Allele-specific RNAi therapy corrects an extracellular matrix defect in Schuurs-Hoeijmakers syndrome
    Lylia Mekzine, Natalia Pinzón, Kamel Mamchaoui, Maria Kondili, Bruno Cadot, Marc Bitoun, Delphine Trochet · 2025 · The American Journal of Human Genetics
  89. Small Interfering RNA Carriers for Oncotherapy: A Preclinical Overview
    Liliana Aranda‐Lara, Alondra Escudero-Castellanos, Maydelid Trujillo-Nolasco, Enrique Morales-Ávila, Blanca Ocampo‐García, Rigoberto Oros‐Pantoja, Virginia Sánchez Monroy, Keila Isaac‐Olivé · 2025 · Pharmaceutics
  90. Interventional Endoscopic Ultrasound
    DavidL Diehl, Kenneth Frank Binmoeller, Nazia Hasan, Mouen A. Khashab, Rami G. El Abiad, David E. Loren · 2026 · Gastroenterology
  91. Non-coding RNAs in gene therapy: mechanisms, delivery strategies, and clinical translation
    Ali Abuhaliema, Lobna Gharaibeh, Eman Jaradat, Mohaned Hammad, Walhan Alshaer · 2026 · Pharmacia
  92. KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers
    Man Yan, Kai Liu, Jiayi Xu, Yandi Liu, Liechen Ji, Shiwu Zhang · 2026 · Molecular Cancer
  93. From edits to Circuits: Nucleic acid therapeutics for Correcting human disease
    Michael Tyler Guinn, Irina Sinenko, Ravi K. Ghanta, Omid Veiseh A · 2026 · Materials Today
  94. Genomic innovations in cancer prevention, diagnosis, prognosis and precision therapeutics
    Hanumappa Ananda, Sadhu R. Sahana, Shruthi R. Murthy, Amrutha Nedumbrakkad Kunnath, Akila Prashant, Jussuf T. Kaifi, Pura Krishnamurthy Kiran, Kanve Nagaraj Suvilesh · 2026 · Frontiers in Genetics
  95. Targeting lncRNAs to Overcome Cancer Therapy Resistance: Advances in RNA Therapeutics and Delivery Strategies
    Christos Drosos, Athina Kapsi, Anthi Nikolaidou, Antonis Giakountis · 2026 · Cancers
  96. Current and Emerging Therapies in Pancreatic Cancer
    Maria Diab, Philip A. Philip · 2017 · Springer eBooks
  97. Precision Approaches to Pancreatic Cancer Therapy: What Now and What Next?
    Fergus Keane, Wungki Park, Eileen Mary O'Reilly · 2022 · Current Treatment Options in Gastroenterology
  98. Role of Epigenetics Variation with Focus on DNA Methylation in Triple-Negative Breast Cancer Patients
    G. Deepthi Reddy, V Brahmaiah, B. Y. Kavitha, Jayalatha Nethagani, Elizabeth Caroline Palaparthi, Rajasekhar Reddy Lebaka, G. Deepika · 2023 · Archives of Medicine and Health Sciences
  99. Small RNAs in Cancer Therapy
    Yufei Pan, Quanxin Wang, Yuan Ma · 2024 · Interdisciplinary cancer research
  100. Emerging Technologies for the Diagnosis and Treatment of Pancreatic Cancer
    Magdalena Swierczewska, С. В. Козлов, Pavan P. Adiseshaiah · 2018 · Elsevier eBooks